These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11867363)

  • 1. Rapacuronium and the risk of bronchospasm in pediatric patients.
    Rajchert DM; Pasquariello CA; Watcha MF; Schreiner MS
    Anesth Analg; 2002 Mar; 94(3):488-93; table of contents. PubMed ID: 11867363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchospasm after rapacuronium in infants and children.
    Meakin GH; Pronske EH; Lerman J; Orr R; Joffe D; Savaree AM; Lynn AM
    Anesthesiology; 2001 May; 94(5):926-7. PubMed ID: 11388548
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapacuronium and bronchospasm.
    Goudsouzian NG
    Anesthesiology; 2001 May; 94(5):727-8. PubMed ID: 11388519
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe bronchospasm and desaturation in a child associated with rapacuronium.
    Kron SS
    Anesthesiology; 2001 May; 94(5):923-4. PubMed ID: 11388546
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect on lung mechanics in anesthetized children with rapacuronium: a comparative study with mivacurium.
    Fine GF; Motoyama EK; Brandom BW; Fertal KM; Mutich R; Davis PJ
    Anesth Analg; 2002 Jul; 95(1):56-61, table of contents. PubMed ID: 12088943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How serious is the bronchospasm induced by rapacuronium?
    Naguib M
    Anesthesiology; 2001 May; 94(5):924-5. PubMed ID: 11388547
    [No Abstract]   [Full Text] [Related]  

  • 7. Another possible mechanism for bronchospasm after rapacuronium.
    Stuth EA; Stucke AG; Setlock MA
    Anesthesiology; 2002 Jun; 96(6):1528-9. PubMed ID: 12170075
    [No Abstract]   [Full Text] [Related]  

  • 8. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
    Jooste E; Klafter F; Hirshman CA; Emala CW
    Anesthesiology; 2003 Apr; 98(4):906-11. PubMed ID: 12657852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapacuronium redux.
    Schulman SR
    Anesth Analg; 2002 Mar; 94(3):483-4. PubMed ID: 11867361
    [No Abstract]   [Full Text] [Related]  

  • 10. A dose-ranging study of rapacuronium in pediatric patients.
    Meakin GH; Meretoja OA; Motsch J; Taivainen T; Wirtavuori K; Schönstedt R; Perkins R; McCluskey A
    Anesthesiology; 2000 Apr; 92(4):1002-9. PubMed ID: 10754619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of rapacuronium bromide.
    Wight WJ; Wright PM
    Clin Pharmacokinet; 2002; 41(13):1059-76. PubMed ID: 12403643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of rapacuronium bromide, a new short-acting neuromuscular blocking agent.
    Larijani GE; Zafeiridis A; Goldberg ME
    Pharmacotherapy; 1999 Oct; 19(10):1118-22. PubMed ID: 10512060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapacuronium: why did it fail as a replacement for succinylcholine?
    White PF
    Br J Anaesth; 2002 Feb; 88(2):163-5. PubMed ID: 11878650
    [No Abstract]   [Full Text] [Related]  

  • 16. Intramuscular rapacuronium in infants and children: a comparative multicenter study to confirm the efficacy and safety of the age-related tracheal intubating doses of intramuscular rapacuronium (ORG 9487) in two groups of pediatric subjects.
    Denman WT; Kaplan RF; Goudsouzian NG; Uejima T; Barcelona SL; Cote CJ; Ginsberg B; Hannallah RS
    Anesthesiology; 2001 Jan; 94(1):3-7. PubMed ID: 11135715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapacuronium: premarket drug evaluation can be very effective for the identification of drug risks.
    Lim R
    Anesth Analg; 2003 Feb; 96(2):631-2. PubMed ID: 12538231
    [No Abstract]   [Full Text] [Related]  

  • 18. The potency (ED50) and cardiovascular effects of rapacuronium (Org 9487) during narcotic-nitrous oxide-propofol anesthesia in neonates, infants, and children.
    Kaplan RF; Fletcher JE; Hannallah RS; Bui DT; Slaven JS; Darrow EJ; Tsai KT
    Anesth Analg; 1999 Nov; 89(5):1172-6. PubMed ID: 10553829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapacuronium: clinical pharmacology.
    Mirakhur RK; McCourt KC
    Eur J Anaesthesiol Suppl; 2001; 23():77-82. PubMed ID: 11766252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intubating conditions after rapacuronium (Org 9487) and succinylcholine following rapid sequence induction in adult patients.
    Sparr HJ; Mellinghoff H; Blobner M; Nöldge-Schomburg G
    Br J Anaesth; 1999 Apr; 82(4):537-41. PubMed ID: 10472218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.